[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 Global Radioactive Monoclonal Antibody Industry Report - History, Present and Future

December 2018 | 148 pages | ID: 2909DFE3CD2PEN
Prof Research

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global market size of Radioactive Monoclonal Antibody is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Radioactive Monoclonal Antibody as well as some small players. The compnaies include:

Pfizer Inc. (USA), Abbott Laboratories (USA), Genentech Inc. (USA), GlaxoSmithKline Plc (UK), Immunomedics, Inc. (USA), Indevus Pharmaceuticals Inc. (USA), Novartis AG (Switzerland), OSI Pharmaceutica et al.

The information for each competitor includes:
  • Company Profile
  • Main Business Information
  • SWOT Analysis
  • Sales, Revenue, Price and Gross Margin
  • Market Share
We also can offer customized report to fulfill special requirements of our clients.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Radioactive Monoclonal Antibody Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Radioactive Monoclonal Antibody by Region
8.2 Import of Radioactive Monoclonal Antibody by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT RADIOACTIVE MONOCLONAL ANTIBODY MARKET IN NORTH AMERICA (2013-2018)

9.1 Radioactive Monoclonal Antibody Supply
9.2 Radioactive Monoclonal Antibody Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT RADIOACTIVE MONOCLONAL ANTIBODY MARKET IN SOUTH AMERICA (2013-2018)

10.1 Radioactive Monoclonal Antibody Supply
10.2 Radioactive Monoclonal Antibody Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT RADIOACTIVE MONOCLONAL ANTIBODY MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Radioactive Monoclonal Antibody Supply
11.2 Radioactive Monoclonal Antibody Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT RADIOACTIVE MONOCLONAL ANTIBODY MARKET IN EUROPE (2013-2018)

12.1 Radioactive Monoclonal Antibody Supply
12.2 Radioactive Monoclonal Antibody Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT RADIOACTIVE MONOCLONAL ANTIBODY MARKET IN MEA (2013-2018)

13.1 Radioactive Monoclonal Antibody Supply
13.2 Radioactive Monoclonal Antibody Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL RADIOACTIVE MONOCLONAL ANTIBODY MARKET (2013-2018)

14.1 Radioactive Monoclonal Antibody Supply
14.2 Radioactive Monoclonal Antibody Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL RADIOACTIVE MONOCLONAL ANTIBODY MARKET FORECAST (2019-2023)

15.1 Radioactive Monoclonal Antibody Supply Forecast
15.2 Radioactive Monoclonal Antibody Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(PFIZER INC. (USA), ABBOTT LABORATORIES (USA), GENENTECH INC. (USA), GLAXOSMITHKLINE PLC (UK), IMMUNOMEDICS, INC. (USA), INDEVUS PHARMACEUTICALS INC. (USA), NOVARTIS AG (SWITZERLAND), OSI PHARMACEUTICA ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Radioactive Monoclonal Antibody Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Radioactive Monoclonal Antibody Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Radioactive Monoclonal Antibody Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Radioactive Monoclonal Antibody Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Radioactive Monoclonal Antibody Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Radioactive Monoclonal Antibody Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Radioactive Monoclonal Antibody Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2013-2018)

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Radioactive Monoclonal Antibody Report
Table Primary Sources of Radioactive Monoclonal Antibody Report
Table Secondary Sources of Radioactive Monoclonal Antibody Report
Table Major Assumptions of Radioactive Monoclonal Antibody Report
Figure Radioactive Monoclonal Antibody Picture
Table Radioactive Monoclonal Antibody Classification
Table Radioactive Monoclonal Antibody Applications List
Table Drivers of Radioactive Monoclonal Antibody Market
Table Restraints of Radioactive Monoclonal Antibody Market
Table Opportunities of Radioactive Monoclonal Antibody Market
Table Threats of Radioactive Monoclonal Antibody Market
Table Key Raw Material of Radioactive Monoclonal Antibody and Its Suppliers
Table Key Technologies of Radioactive Monoclonal Antibody
Table Cost Structure of Radioactive Monoclonal Antibody
Table Market Channel of Radioactive Monoclonal Antibody
Table Radioactive Monoclonal Antibody Application and Key End Users List
Table Latest News of Radioactive Monoclonal Antibody Industry
Table Recently Merger and Acquisition List of Radioactive Monoclonal Antibody Industry
Table Recently Planned/Future Project List of Radioactive Monoclonal Antibody Industry
Table Policy Dynamics Update of Radioactive Monoclonal Antibody Industry
Table 2013-2023 Export of Radioactive Monoclonal Antibody by Region
Table 2013-2023 Import of Radioactive Monoclonal Antibody by Region
Table 2013-2023 Balance of Trade of Radioactive Monoclonal Antibody
Figure 2013 2018 and 2023 Global Trade Map of Radioactive Monoclonal Antibody
Table 2013-2018 North America Supply of Radioactive Monoclonal Antibody
Figure 2013-2018 North America Radioactive Monoclonal Antibody Supply and GAGR
Table 2013-2018 North America Radioactive Monoclonal Antibody Downstream Demand List
Figure 2013-2018 North America Radioactive Monoclonal Antibody Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Radioactive Monoclonal Antibody Demand by Type
Figure 2013-2018 North America Radioactive Monoclonal Antibody Price
Table 2013-2018 Key Countries Supply of Radioactive Monoclonal Antibody in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Radioactive Monoclonal Antibody in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Radioactive Monoclonal Antibody
Figure 2013-2018 South America Radioactive Monoclonal Antibody Supply and GAGR
Table 2013-2018 South America Radioactive Monoclonal Antibody Downstream Demand List
Figure 2013-2018 South America Radioactive Monoclonal Antibody Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Radioactive Monoclonal Antibody Demand by Type
Figure 2013-2018 South America Radioactive Monoclonal Antibody Price
Table 2013-2018 Key Countries Supply of Radioactive Monoclonal Antibody in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Radioactive Monoclonal Antibody in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Radioactive Monoclonal Antibody
Figure 2013-2018 Asia & Pacific Radioactive Monoclonal Antibody Supply and GAGR
Table 2013-2018 Asia & Pacific Radioactive Monoclonal Antibody Downstream Demand List
Figure 2013-2018 Asia & Pacific Radioactive Monoclonal Antibody Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Radioactive Monoclonal Antibody Demand by Type
Figure 2013-2018 Asia & Pacific Radioactive Monoclonal Antibody Price
Table 2013-2018 Key Countries Supply of Radioactive Monoclonal Antibody in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Radioactive Monoclonal Antibody in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Radioactive Monoclonal Antibody
Figure 2013-2018 Europe Radioactive Monoclonal Antibody Supply and GAGR
Table 2013-2018 Europe Radioactive Monoclonal Antibody Downstream Demand List
Figure 2013-2018 Europe Radioactive Monoclonal Antibody Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Radioactive Monoclonal Antibody Demand by Type
Figure 2013-2018 Europe Radioactive Monoclonal Antibody Price
Table 2013-2018 Key Countries Supply of Radioactive Monoclonal Antibody in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Radioactive Monoclonal Antibody in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Radioactive Monoclonal Antibody
Figure 2013-2018 MEA Radioactive Monoclonal Antibody Supply and GAGR
Table 2013-2018 MEA Radioactive Monoclonal Antibody Downstream Demand List
Figure 2013-2018 MEA Radioactive Monoclonal Antibody Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Radioactive Monoclonal Antibody Demand by Type
Figure 2013-2018 MEA Radioactive Monoclonal Antibody Price
Table 2013-2018 Key Countries Supply of Radioactive Monoclonal Antibody in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Radioactive Monoclonal Antibody in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Radioactive Monoclonal Antibody by Region
Figure 2013-2018 Global Supply and CAGR of Radioactive Monoclonal Antibody by Region
Table 2013-2018 Global Radioactive Monoclonal Antibody Downstream Demand List by Region
Figure 2013-2018 Global Radioactive Monoclonal Antibody Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Radioactive Monoclonal Antibody Type-wise Demand by Region
Figure 2013-2018 Global Radioactive Monoclonal Antibody Price
Table Main Business and Radioactive Monoclonal Antibody Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company A Radioactive Monoclonal Antibody Market Share
Table Main Business and Radioactive Monoclonal Antibody Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company B Radioactive Monoclonal Antibody Market Share
Table Main Business and Radioactive Monoclonal Antibody Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company C Radioactive Monoclonal Antibody Market Share
Table Main Business and Radioactive Monoclonal Antibody Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company D Radioactive Monoclonal Antibody Market Share
Table Main Business and Radioactive Monoclonal Antibody Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company E Radioactive Monoclonal Antibody Market Share
Table Main Business and Radioactive Monoclonal Antibody Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company F Radioactive Monoclonal Antibody Market Share
Table Main Business and Radioactive Monoclonal Antibody Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Radioactive Monoclonal Antibody Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Radioactive Monoclonal Antibody Sales Revenue and Growth Rate
Figure 2013-2018 Company G Radioactive Monoclonal Antibody Market Share


More Publications